Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04607772
Title Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Karyopharm Therapeutics Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.